About Grassfed Ventures
Grassfed Ventures Inc. is a venture capital and advisory firm focused on the cannabis, life sciences, and eSports industries. Our expertise lies in rapid scaling and operationalization of emerging companies that are primed for explosive growth. We pour fuel on the fire for these ventures through access to capital, direct investments and tailored growth-focused advice. Our mission is to help world-class entrepreneurs and game-changing technologies become leaders and create impact in record time. As a policy, we only invest and advise companies where we believe we can add massive value and provide hands-on insight and advice.
Grassfed Ventures was founded by the three entrepreneurs who created Canadian Cannabis Clinics and CanvasRx (30 locations; 50,000 patients on roster) and helped build Aurora Cannabis Inc. (TSX: ACB) into one of the world’s largest cannabis companies. In addition to their pioneering work in the cannabis industry, Grassfed Ventures’ founders have executed and succeeded in a variety of fields.
Joseph del Moral
Joseph is a serial entrepreneur and founder of Grassfed Ventures. He was the founder and CEO of CanvasRX which grew to be the largest cannabis clinic in Canada. After selling the company to Aurora Cannabis he joined their board of directors and, along with his partners led Aurora’s merger & acquisition and corporate development efforts resulting in over a dozen transactions. Prior to that Joseph co-founded Newten Home Comfort, a fast growing home services company acquired by Just Energy Inc. (JE.TO) in 2012. Prior to starting and growing Canadian Cannabis Clinics and CanvasRx, Joseph co-founded Newten Home Comfort, a fast growing home services company acquired by Just Energy Inc. (JE.TO) in 2012. He holds a Bachelor of Commerce Degree (Finance and Entrepreneurship) from McGill University.
An entrepreneur and a visionary, Ronan is one the founders of Field Trip. Concurrent with his work at Field Trip, he is a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences Inc., a leading biotech company in the hemp and cannabis industries. Ronan also serves on the Board of Directors of Province Brands. Prior to his current roles, Ronan (along with Joseph, Hannan and Ryan) co-founded Canadian Cannabis Clinics and CanvasRx Inc., the latter of which was acquired by Aurora Cannabis Inc. (NYSE: ACB) in 2016, after which he served as Senior Vice President, Business and Corporate Affairs for Aurora. A lawyer by training, Ronan started his career as a corporate lawyer at Blake, Cassels Graydon LLP and Legal Counsel at CTVglobemedia Inc. (now Bell Media Inc.) He holds a Juris Doctor and a Bachelor of Commerce degree, both from the University of Toronto.
Hannan is a founder of Grassfed Ventures. Earlier in his career, Hannan was Vice President of Operations of National Home Services, a subsidiary of Just Energy Inc. (JE.TO) and a Senior Business Manager at Teva Pharmaceuticals Inc. where he managed the Hospital, OTC and Animal Care divisions. He holds an MBA from McMaster University and a Bachelor of Science degree from the University of Guelph.
Lobo Genetics enables safer cannabis use through DNA testing. Consumers and patients can gain actionable insights into their personal response to cannabis based on their genetic profile. Lobo's portable device platform provides results in under an hour, and can be deployed in medical clinics, dispensaries, pharmacies or retail outlets. With applications across the recreational, medical and clinical space, Lobo is bringing the science of cannabis genetics to everyone.
Trait Biosciences Inc. is a leading biotechnology research organization delivering proprietary science in cannabinoid cultivation and product development.
Field Trip’s mission is to heal the sick, and better the well, through therapeutic psychedelics. Field Trip is a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics value chain — from basic research on botanical psychedelics to operation of world-class clinics focussed on psychedelics-assisted therapies.